MyAverix Finance MyAverix Finance

LSE

Newron Pharmaceuticals S.p.A. (0QOI)

Newron Pharmaceuticals S.p.A. (0QOI) is listed on LSE. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-23

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 0QOI

P/E ratio
18.00

Newron Pharmaceuticals S.p.A. (0QOI) — FAQ

What is 0QOI's P/E ratio?

The price-to-earnings (P/E) ratio for Newron Pharmaceuticals S.p.A. (0QOI) is 18.00 (data as of 2026-05-23).

Does Newron Pharmaceuticals S.p.A. pay a dividend?

Dividend yield is not available in the current snapshot for Newron Pharmaceuticals S.p.A. (0QOI). Check the MyAverix Finance app for the latest dividend data.

What exchange is 0QOI listed on?

0QOI is listed on LSE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play